Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PolyPEPI1018 |
Synonyms | |
Therapy Description |
PolyPEPI1018 is a cancer vaccine comprising peptides derived from seven tumor-associated antigens commonly expressed in colorectal cancer, which potentially results in increased antitumor immune response (PMID: 35472243). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PolyPEPI1018 | PolyPEPI-1018|PolyPEPI 1018 | PolyPEPI1018 is a cancer vaccine comprising peptides derived from seven tumor-associated antigens commonly expressed in colorectal cancer, which potentially results in increased antitumor immune response (PMID: 35472243). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03391232 | Phase I | PolyPEPI1018 | Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) | Completed | USA | ITA | 0 |